Related Experiment Videos
GABA(B) receptor alterations as indicators of physiological and pharmacological function
1Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical School, 3901 Rainbow Boulevard, Mail Stop 1018, Kansas City, Kansas 66160-0227, USA. senna@kumc.edu
Biochemical Pharmacology
|September 29, 2004
Summary
Targeting GABA(B) receptors, crucial for central nervous system functions, shows therapeutic potential for various disorders. Research indicates GABA(B) receptor modifications are linked to treatment responses and symptoms of neurological conditions.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- GABA(B) receptors are widely distributed in the central and peripheral nervous systems.
- Selective pharmacological manipulation of GABA(B) receptors may offer therapeutic benefits for diverse disorders.
Purpose of the Study:
- To define the clinical potential of GABA(B) receptor agonists and antagonists.
- To investigate the role of GABA(B) receptor subunits and their function in disease states and drug treatment.
Main Methods:
- Gene deletion experiments.
- Analysis of receptor binding, subunit expression, and function in diseased tissues.
- Assessment of receptor changes after chronic drug administration.
Main Results:
- A functional GABA(B) receptor requires both GABA(B(1)) and GABA(B(2)) subunits.
- Receptor function may not consistently correlate with subunit expression or binding.
- GABA(B) receptor modifications are potentially associated with clinical responses to various psychotropic medications and GABA(B) modulators.
Conclusions:
- GABA(B) receptor alterations are implicated in symptoms of chronic pain, epilepsy, and schizophrenia.
- Developing drugs that selectively modulate GABA(B) receptor activity holds significant therapeutic promise.